• OPEN AN ACCOUNT
Indian Indices
Nifty
22,502.00 35.90
(0.16%)
Sensex
74,005.94 88.91
( 0.12%)
Bank Nifty
48,199.50 83.85
( 0.17%)
Nifty IT
33,438.75 56.90
( 0.17%)
Global Indices
Nasdaq
16,685.97 -12.35
(-0.07%)
Dow Jones
40,003.59 134.21
(0.34%)
Hang Seng
19,553.61 177.08
(0.91%)
Nikkei 225
38,787.38 -132.88
(-0.34%)
Forex
USD-INR
83.47 0.01
(0.01%)
EUR-INR
90.76 0.22
(0.25%)
GBP-INR
105.79 0.36
(0.34%)
JPY-INR
0.54 0.00
(0.51%)

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524632
INE551C01028
10.1085326
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
28.52
528.26
EPS(TTM)
Face Value()
Div & Yield %
4.23
10
0.04
 

shukra pharmaceuticals ltd
Shukra Pharmaceuticals Ltd - Board Meeting Intimation for For Considering And Approving The Unaudited Financial Result For The Quarter Ended On December 31 2023
Feb 03,2024
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve 1. Unaudited Financial Result for the quarter ended on December 31 2023 along with the Limited Review Report of the Auditor pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015. 2. Any other business with the permission of Chairman.